Startup India Government of India
Srivijitha Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹7.88 Cr
▲ 101% YoY
Net profit · FY 2022
₹1.16 Cr
Net margin 14.7%
EBITDA · FY 2022
₹1.17 Cr
EBITDA margin 14.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1.5 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Srivijitha Pharmaceuticals Private Limited
Data last updated:
Srivijitha Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2017PTC121033. Its GSTIN is 36AAZCS5541A1Z4 (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors including Srinivasa Reddy Inkollu and Raghuveer Nukala Reddy.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2022, the company reported a revenue of ₹7.88 Cr, a growth of 101% compared to the previous year. For the same year it recorded a net profit of ₹1.16 Cr (net margin 14.7%) and EBITDA of ₹1.17 Cr (EBITDA margin 14.8%). Revenue has grown at a compounded annual rate (CAGR) of 67% over three years.
Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website srivijitha.com.
Company details
CIN U74999TG2017PTC121033
Registration Number 121033
Incorporation Date 06 December 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Key People
Srinivasa Reddy Inkollu Director Raghuveer Nukala Reddy Director Anjaneyulu Kasa Director Recognitions & Rankings of Srivijitha Pharmaceuticals
Contact details
Srivijitha Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is srivijitha.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 141/B 2nd Floor Phase 2 Road No. 14 Ida Mallapur Medchal – Malka, Jgiri, Hyderabad, Telangana, India – 500076
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Srivijitha Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Srivijitha Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Srivijitha Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Srivijitha Pharmaceuticals Private Limited, buy the company report.
Financials of Srivijitha Pharmaceuticals Private Limited
FY 2022 filings availableSrivijitha Pharmaceuticals Private Limited reported revenue of ₹7.88 Cr (up 101% YoY) for FY 2022.
Revenue · FY 2022
₹7.88 Cr ▲ 101%
Net profit · FY 2022
₹1.16 Cr margin 14.7%
EBITDA · FY 2022
₹1.17 Cr margin 14.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 101%
3 years · compounded
▲ 67%
EBITDA CAGR growth
1 year
▲ 445%
3 years · compounded
▲ 60%
Revenue has grown at a compounded annual rate (CAGR) of 67% over three years, including 101% growth in the latest year. EBITDA rose 445% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹7.88 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.17 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.16 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.8% | ||||
| Net Profit Margin | 14.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Srivijitha Pharmaceuticals Private Limited, buy the company report.
Board of directors of Srivijitha Pharmaceuticals Private Limited
Srivijitha Pharmaceuticals has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasa Reddy Inkollu | Director | 20 Sep 2018 | 8 Years 1 Months | Current |
| Raghuveer Nukala Reddy | Director | 20 Sep 2018 | 8 Years 1 Months | Current |
| Anjaneyulu Kasa | Director | 06 Mar 2019 | 7 Years 7 Months | Current |
Auditor
Srivijitha Pharmaceuticals Private Limited is audited by T VISHAL & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| T VISHAL & ASSOCIATES | FY 2022 | 019243S |
Shareholding
The shareholding of Srivijitha Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Srivijitha Pharmaceuticals Private Limited, buy the company report.
Legal cases
Srivijitha Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Srivijitha Pharmaceuticals. All case is pending.
Total cases
1
Filed by the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed by the company against M/S Curequest Lifescience LLP Rep., by Its Managing Partner | Pending |
To see the full case history of Srivijitha Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Srivijitha Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Srivijitha Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAZCS5541A1Z4 | Telangana | Active | 10 Jan 2018 |
To see the full GST registrations and return filing status of Srivijitha Pharmaceuticals Private Limited, buy the company report.
Recent activity
Srivijitha Pharmaceuticals Private Limited has 9 board changes on record since 2018: 3 appointments and 6 cessations. The latest: China Kondareddy Sangana ceased to be Director on 01 Apr 2021.
AGM
Srivijitha Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Srivijitha Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad.
Ceased
China Kondareddy Sangana ceased to be Director.
Ceased
Madhavi Peddinti ceased to be Director.
Ceased
Ramesh Manepalli ceased to be Managing Director.
Appointed
Anjaneyulu Kasa was appointed as Director.
Ceased
Hemantha Kasa ceased to be Director.
Ceased
Venkataramana Sangana ceased to be Director.
Appointed
Raghuveer Nukala Reddy was appointed as Director.
Appointed
Srinivasa Reddy Inkollu was appointed as Director.
Ceased
Sai Babu Jada ceased to be Director.
Incorporation
06 Dec 2017
Srivijitha Pharmaceuticals Private Limited was registered on 06 Dec 2017 with Roc Hyderabad & aged 8 years 10 months as per MCA records.
Frequently asked questions
Srivijitha Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 December 2017 (9+ years old) and is registered under CIN U74999TG2017PTC121033.
Srivijitha Pharmaceuticals has 3 current directors:
- Srinivasa Reddy Inkollu - Director
- Raghuveer Nukala Reddy - Director
- Anjaneyulu Kasa - Director
The latest financial statements of Srivijitha Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Srivijitha Pharmaceuticals is 36AAZCS5541A1Z4, registered in Telangana.
The CIN (Corporate Identification Number) of Srivijitha Pharmaceuticals is U74999TG2017PTC121033. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Srivijitha Pharmaceuticals has 1 court case on record: 1 filed by the company. 1 is pending.
Srivijitha Pharmaceuticals was incorporated on 06 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
China Kondareddy Sangana ceased to be Director on 01 Apr 2021. Madhavi Peddinti ceased to be Director on 01 Apr 2021. Ramesh Manepalli ceased to be Managing Director on 22 Jul 2020. Srivijitha Pharmaceuticals has 9 board changes on record in total.
Yes, Srivijitha Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Srivijitha Pharmaceuticals can be reached through the website srivijitha.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages